Fei Ma

机构：University of Fribourg, Breast Cancer Research Foundation, Chinese Academy of Medical Sciences & Peking Union Medical College, Hainan University, National Cancer Center, National Clinical Research, Xi’an Jiaotong-Liverpool University · ORCID：0000-0001-9432-1902

发表论文 737 篇 · 总被引 10665 次 · h-index 48

代表论文

• Biologically-informed integration of drug representations for breast cancer treatment using deep learning (2025 · Nature Communications · 被引 3)
• Neutrophil-mediated immune dysregulation in recurrent miscarriage: implications of APP–CD74 signaling and CXCL1 as diagnostic biomarkers (2025 · Frontiers in Immunology · 被引 3)
• Associations between dynamic hematological indicators and outcomes in HR-positive, HER2-negative metastatic breast cancer treated with bireociclib or placebo plus fulvestrant: Findings from the BRIGHT-2 trial (2025 · The Breast · 被引 3)
• Correlation Between the Prognostic Nutritional Index and Breast Cancer in U.S. Adults: NHANES 2001–2018 (2025 · Nutrition and Cancer · 被引 2)
• Pathological complete response and survival outcomes in single hormone receptor-positive/HER2-negative breast cancer after neoadjuvant chemotherapy and its intrinsic biological features and immune landscape (2025 · Breast Cancer Research and Treatment · 被引 2)
• Metronomic Chemotherapy in Breast Cancer: Unleashing the Potential of Combination Regimens (2025 · Cancer Innovation · 被引 1)